Transferator (TRAN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Feb, 2026Executive summary
Revenue for Q4 2025 was 13.9 Mkr, down from 16.4 Mkr year-over-year; full-year revenue was 55.9 Mkr, nearly flat from 55.1 Mkr in 2024.
EBITDA for Q4 was -0.1 Mkr (2.4 Mkr in Q4 2024); full-year EBITDA improved to 5.8 Mkr from 4.5 Mkr.
Net income for 2025 was 1.9 Mkr excluding a one-time accounting effect; including the effect, net income was 21.5 Mkr.
A positive one-time accounting effect of 19.6 Mkr was recognized in Q4, related to reclassification of prior withdrawals from a corporate-owned insurance policy.
Liquidity declined, with cash at year-end at 1.7 Mkr versus 17.9 Mkr a year earlier.
Financial highlights
Q4 revenue decreased due to weaker performance in the ABG group; full-year revenue stable.
Q4 EBITDA turned negative, mainly due to lower sales in ABG; full-year EBITDA increased.
Depreciation for the year was -2.6 Mkr, down from -6.1 Mkr in 2024.
Financial items for the year totaled 19.1 Mkr, including the 19.6 Mkr one-time effect.
Equity per share rose to 0.74 kr from 0.51 kr; solidity improved to 69.7% from 67.1%.
Outlook and guidance
Early 2026 activity and sales levels are in line with expectations and closer to normal.
No dividend is proposed for 2025.
Latest events from Transferator
- Revenue up, net income flat; sector weakness offset by other segments, Q-Linea loss weighs.TRAN
Q3 202529 Nov 2025 - Stable sales and EBITDA, but net profit fell sharply without last year’s one-off gains.TRAN
Q2 202529 Aug 2025 - Q3 net loss driven by Hedera write-downs, but nine-month profit rose on ELKAB earn-outs.TRAN
Q3 202413 Jun 2025 - Net income rose sharply to 39.4 MSEK, with improved equity ratio and strong liquidity.TRAN
Q2 202413 Jun 2025 - Stable operations but net loss in Q1 2025 as one-time gains were not repeated.TRAN
Q1 20256 Jun 2025 - Net income jumped to 36.8 MSEK in 2024, driven by ELKAB Studios AB earn-outs.TRAN
Q4 20246 Jun 2025